What is Structural Valve Intervention?
Structural Valve Intervention is an advanced, minimally invasive approach used to treat diseases affecting the heart valves. Instead of performing traditional open-heart surgery, doctors can often repair or replace a damaged valve using specialised catheters inserted through a blood vessel, usually in the groin.
These procedures are commonly recommended for patients with conditions such as aortic stenosis, mitral regurgitation, tricuspid valve disease, or degeneration of previously implanted heart valves. Using advanced imaging guidance, the cardiology team carefully navigates the catheter to the heart and performs the required repair or replacement while the heart continues to function normally.
Some of the most commonly performed procedures include Transcatheter Aortic Valve Replacement (TAVR/TAVI), MitraClip therapy for mitral valve repair, transcatheter mitral valve replacement, balloon valvuloplasty, and valve-in-valve procedures. The choice of treatment depends on the type and severity of the valve disease, the patient’s overall health, and individual treatment goals.
One of the major advantages of these interventions is that they usually involve smaller incisions, less discomfort, shorter hospital stays, and quicker recovery compared to conventional surgery. Many patients notice significant improvement in symptoms such as breathlessness, fatigue, chest discomfort, and reduced exercise tolerance soon after treatment.
A thorough evaluation by a multidisciplinary heart team helps determine the most suitable treatment plan and ensures the best possible outcome for each patient.
Types of Structural Valve Interventions
Structural valve interventions are advanced minimally invasive procedures used to treat diseased heart valves without the need for conventional open-heart surgery. By accessing the heart through blood vessels using specialised catheters, cardiologists can repair or replace damaged valves while reducing recovery time and procedural risk for many patients.
1. Aortic Valve Interventions
- Transcatheter Aortic Valve Replacement (TAVR/TAVI): TAVR, also called TAVI, is widely used to treat severe aortic stenosis. During the procedure, a replacement valve is delivered through a catheter, most often through an artery in the groin, and positioned inside the diseased valve. Once deployed, the new valve takes over the job of regulating blood flow from the heart.
- Balloon Aortic Valvuloplasty (BAV): In this procedure, a small balloon mounted on a catheter is guided to the narrowed aortic valve and inflated. The balloon helps widen the valve opening and improve blood flow. Although the results may not be permanent, BAV can provide symptom relief and may serve as a bridge to valve replacement.
- Aortic Valve-in-Valve Procedures: When a previously implanted tissue valve begins to wear out, a new transcatheter valve can often be placed inside the existing valve. This approach avoids repeat open-heart surgery and is particularly valuable for older patients or those at increased surgical risk.
2. Mitral Valve Interventions
- Transcatheter Edge-to-Edge Repair (TEER): TEER is designed for patients with significant mitral regurgitation, where the valve does not close properly and allows blood to leak backward. Devices such as MitraClip and PASCAL help bring the valve leaflets together, improving valve function and reducing symptoms.
- Transcatheter Mitral Valve Replacement (TMVR): TMVR offers a catheter-based alternative for replacing the mitral valve. It is generally considered for patients with complex mitral valve disease who may not be suitable candidates for traditional surgery.
- Percutaneous Balloon Mitral Valvuloplasty (PBMV): PBMV is commonly used in selected patients with mitral stenosis. A balloon catheter is inserted across the narrowed valve and inflated to separate fused valve leaflets, allowing blood to flow more freely.
3. Tricuspid Valve Interventions
- Transcatheter Tricuspid Valve Repair: For patients with severe tricuspid regurgitation, catheter-based repair techniques can help improve valve closure and reduce the volume of blood leaking backward through the valve.
- Transcatheter Tricuspid Valve Replacement (TTVR): TTVR is a newer treatment option that enables complete replacement of the tricuspid valve without open-heart surgery. Advances in device technology are expanding treatment possibilities for patients with complex tricuspid valve disease.
4. Pulmonary Valve Interventions
- Transcatheter Pulmonary Valve Implantation (TPVI): TPVI is frequently used in patients with congenital heart disease who develop pulmonary valve dysfunction. The procedure allows a replacement valve to be implanted through a catheter, restoring normal blood flow between the heart and lungs.
5. Adjunctive Structural Procedures
- Percutaneous Paravalvular Leak Closure: Occasionally, small gaps can develop around a surgically implanted valve, leading to leakage. These leaks can often be sealed using specially designed closure devices delivered through a catheter, helping improve valve performance and relieve symptoms.
Structural valve interventions continue to transform the treatment of heart valve disease. With ongoing advances in technology and imaging, many patients can now receive effective treatment through minimally invasive approaches that offer faster recovery and excellent long-term outcomes.
| Procedure Name | Structural Valve Intervention |
|---|---|
| Type of Procedure | Minimally invasive catheter-based procedure |
| Type of Anesthesia | Local anesthesia, conscious sedation, or general anesthesia |
| Procedure Duration | 1–4 hours |
| Recovery Duration | A few days to several weeks |
Appointment
Second Opinion
Live Chat
Call
More
